About Evans Baroque Ltd
Evans Baroque Ltd (formerly Miral Pharm. Limited) is your trusted healthcare partner. EB provides a trans-national platform for the manufacturing, distribution and marketing of branded generic pharmaceutical products, hospital consumables, and lifestyle goods. At EB, products are made to the highest possible quality and are readily available to the recommended distribution points at prices that represent value.
EB commenced operations in 2012 in Sierra Leone. It successfully implemented a sales and marketing structure with a well spread nationwide distribution network in every major city. It currently has 100 products registered and approved for sale in Sierra Leone and an additional 20 products in registration.
Following the successful launch in Sierra Leone, EB started its Nigerian operations in 2013. Today, with over 80 products in both public health and specialized disease segments, EB is aggressively expanding its footprints in several therapeutic segments – Antibiotics, haematinics, antimalarial, anti-inflammatory, supplements, anti-hypertensives, analgesics, medical/surgical consumables and healthcare kits.
EB is managed by a team of professionals with demonstrable experience and excellence in marketing, sales, manufacturing and distribution of high quality healthcare products and services in Nigeria and across West Africa.
Evans Baroque success so far has been driven by:
– Access to key purchase decision makers with lean and efficient management team.
– Knowledge and access to high quality manufacturing sources.
– Right selection of high quality formulations and products across markets.
In order to extend its growing footprints in Nigeria and in the African region, Miral Pharm Ltd (the precursor company of EB) acquired the manufacturing assets of Evans Medical Plc (formerly Glaxo) in 2018. This manufacturing plant located in Agbara Industrial Estate, sits on 8.3hectares of land and is one of the four Pharmaceutical plants prequalified by the World Health Organization in Nigeria.
Miral Pharm Ltd formally changed its name to Evans Baroque Ltd in 2019.
EB commenced operations in 2012 in Sierra Leone. It successfully implemented a sales and marketing structure with a well spread nationwide distribution network in every major city.
Commenced operations in 2012 in Sierra Leone
With the successful implementation in Sierra Leone, EB launched its Nigerian operations in 2013
Miral Pharm Ltd acquired the manufacturing assets of Evans Medical Plc
Miral Pharm Ltd formally changed its name to Evans Baroque Ltd in 2019